ArticleDrug design, development and therapy2015

Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice.

Michael R Preusch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.